PMOS/PCOS

PMOS — Polycystic Metabolic-Ovarian Syndrome, formerly known as PCOS — affects an estimated 1 in 10 women of reproductive age, and remains one of the most under-funded research areas in endocrinology. The compounds below are studied in literature relevant to insulin signaling, androgenic regulation, metabolic markers, and ovarian function. All products are for in-vitro research use only.